Le Lézard
Classified in: Health, Science and technology
Subjects: AWD, WOM

DotLab named by Reader's Digest as an Amazing Medical Breakthrough of 2018


SAN FRANCISCO, Dec. 6, 2018 /PRNewswire/ -- In its annual review of medical and scientific discoveries, the publication Reader's Digest named DotLab as one of the "Amazing Medical Breakthroughs of 2018." DotLab is recognized for its DotEndo product - the world's first-ever, non-invasive test for endometriosis.

DotLab's non-invasive endometriosis test, DotEndo, named by Reader's Digest as an Amazing Medical Breakthrough of 2018

Approximately one in ten women worldwide are affected by endometriosis, a debilitating chronic disease. Until now, century-old laparoscopic surgery has remained the gold standard in diagnosis. Despite painful symptoms that include pelvic pain, cramping, abnormal menstruation and infertility, many women remain undiagnosed or misdiagnosed and often miss days of school and work. Those who do eventually receive a diagnosis commonly experience a decade-long delay and see an average of five MDs in the process.1,2 

"Today, the gold standard for endometriosis diagnosis requires invasive and expensive laparoscopy, and DotLab is changing the landscape for women's diagnostics through personalized medicine and machine learning," Heather Bowerman, DotLab's CEO and founder said. "As Reader's Digest noted, science is always marching forward, and we are proud to be named as one of the most exciting advancements of the year alongside important technologies across medicine."

  1. Nnoaham KE, et al. Fertil Steril. 2011;96(2):366?373.e8.
  2. Mihalyi A, et al. Hum Reprod. 2010;25(3):654?664.

About DotLab

DotLab is a female-founded personalized medicine company committed to delivering breakthrough diagnostics to women's health. DotLab's first product, DotEndo, uses novel disease-specific biomarkers and machine learning in DotEndo, its proprietary, non-invasive technology to diagnose endometriosis. DotLab's CEO Heather Bowerman has been recognized by Goldman Sachs as one of the 100 Most Intriguing Entrepreneurs, by the MIT Technology Review as one of the world's top 35 innovators, and as a Disruptive Founder of the Year finalist by Rock Health.

About Reader's Digest

Reader's Digest is an American digital and print publication with a print audience of 19.3 million. The publication offers a unique stream of advice, stories, humor, and user-generated content that connects on a personal level with a rapidly growing audience of readers. Its content has the unusual power to inspire, inform and entertain across multiple generations, reinforce optimism and belief in the human spirit. The magazine was founded in 1922 by DeWitt Wallace and Lila Bell Wallace.

SOURCE DotLab


These press releases may also interest you

at 05:12
Swedish Orphan Biovitrum AB (publ) (Sobi®) has established a medium term note programme with a framework amount of SEK 10 billion or the equivalent thereof in EUR (the "MTN Programme"). For this purpose, Sobi has prepared a base prospectus, which...

at 04:00
OMRON Healthcare Co., Ltd. based in Muko, Kyoto Prefecture, Japan, announces to be the official sponsor of May Measurement Month (MMM,) a global campaign to raise awareness of blood pressure screening and promote hypertension prevention, detection,...

at 02:48
Today, RaySearch Laboratories AB (publ)  publishes its Annual Report for the financial year 2023. The report is held available on RaySearch's website, under the section Investors.  This information is information that RaySearch Larboratiories AB...

at 02:43
Shareholders of Zinzino AB (publ) are hereby invited to the annual general meeting on Monday, May 27, 2024, at 1:30 PM at the company's premises at Hulda Mellgrens gata 5 in Gothenburg. Registration begins at 1:15 PM. The company aims to webcast the...

at 02:41
Implantica AG (publ), a med-tech company at the forefront of bringing advanced technology into the body, is publishing its annual report for the fiscal year 2023. The annual report is now available on the company's website. "Implantica had a very...

at 02:08
Revenue amounted to ?498.8m (?419.3m), an increase of 18.9% with an organic growth of 14.2%.Operating profit (EBIT) was ?19.0m (?10.7m), an increase of 78.0%, representing an operating margin of 3.8% (2.6%).Net profit amounted to ?6.5m (?2.1m), which...



News published on and distributed by: